Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis

6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Neurofibromatosis type 1 (NF1) is a rare multisystem genetic disorder. During the course of the disease it can be rarely complicated with pulmonary hypertension (PH) which confers a dismal prognosis. Case presentation: We describe the case of a 57-year-old female patient with NF1 complicated by severe precapillary PH despite dual disease-specific oral combination therapy. The patient was treated with initial atrial septostomy followed by administration of high-dose subcutaneous treprostinil with a favorable medium-term clinical and hemodynamic response. Conclusions: PH secondary to NF1 may be successfully treated with the combination of atrial septostomy and PH targeted therapy in selected patients.

Cite

CITATION STYLE

APA

Giannakoulas, G., Savvoulidis, P., Grosomanidis, V., Mouratoglou, S. A., Karvounis, H., & Hadjimiltiades, S. (2016). Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis. BMC Pulmonary Medicine, 16(1). https://doi.org/10.1186/s12890-016-0337-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free